Solution cocrystallization, an effective tool to explore the variety of cocrystal systems: caffeine/dicarboxylic acid cocrystals
暂无分享,去创建一个
Koen Robeyns | Tom Leyssens | Stéphane Veesler | Nadine Candoni | N. Candoni | S. Veesler | T. Leyssens | K. Robeyns | Natalia Tumanova | N. Tumanova
[1] A. Newman. Specialized Solid Form Screening Techniques , 2013 .
[2] Composition, properties, stability and thermal dehydration of crystalline caffeine hydrate , 1980 .
[3] Peter York,et al. Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: Caffeine/maleic acid. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] Keith Chadwick,et al. The utility of a ternary phase diagram in the discovery of new co-crystal forms , 2009 .
[5] J. Bernstein,et al. Graph-set analysis of hydrogen-bond patterns in organic crystals. , 1990, Acta crystallographica. Section B, Structural science.
[6] C. C. Seaton,et al. Solubility, metastable zone width measurement and crystal growth of the 1:1 benzoic acid/isonicotinamide cocrystal in solutions of variable stoichiometry. , 2010, Journal of pharmaceutical sciences.
[7] R. Tan,et al. Polymorphism in cocrystals: a review and assessment of its significance , 2014 .
[8] Geoff G. Z. Zhang,et al. Co-crystals of caffeine and hydroxy-2-naphthoic acids: unusual formation of the carboxylic acid dimer in the presence of a heterosynthon. , 2007, Molecular pharmaceutics.
[9] L. Fábián,et al. Exploring cocrystal-cocrystal reactivity via liquid-assisted grinding: the assembling of racemic and dismantling of enantiomeric cocrystals. , 2006, Chemical communications.
[10] S. Boerrigter,et al. Cocrystals of nutraceutical p-coumaric acid with caffeine and theophylline: polymorphism and solid-state stability explored in detail using their crystal graphs , 2011 .
[11] M. Eddleston,et al. Polymorphs, hydrates and solvates of a co-crystal of caffeine with anthranilic acid. , 2014, Acta crystallographica Section B, Structural science, crystal engineering and materials.
[13] Katsuhiko Yamamoto,et al. High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate. , 2010, International journal of pharmaceutics.
[14] Peddy Vishweshwar,et al. Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.
[15] S. Childs,et al. The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome , 2009 .
[16] A. Paradkar,et al. Microwave assisted synthesis of caffeine/maleic acid co-crystals: the role of the dielectric and physicochemical properties of the solvent , 2013 .
[17] Richard W. Duerst,et al. Cocrystals of Caffeine and Hydroxybenzoic Acids Composed of Multiple Supramolecular Heterosynthons: Screening via Solution-Mediated Phase Transformation and Structural Characterization , 2009 .
[18] A Rapid Method for Screening Crystallization Conditions and Phases of an Active Pharmaceutical Ingredient , 2009 .
[19] William Jones,et al. Pharmaceutical Cocrystals: An Emerging Approach to Physical Property Enhancement , 2006 .
[20] Gargi Mukherjee,et al. Polymorphs, Salts, and Cocrystals: What’s in a Name? , 2012 .
[21] Ning Shan,et al. The role of cocrystals in pharmaceutical science. , 2008, Drug discovery today.
[22] P. W. Cains,et al. Co-Crystal Polymorphs from a Solvent-Mediated Transformation , 2008 .
[23] David R. Weyna,et al. Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs Slow Evaporation from Solution , 2009 .
[24] H. Brittain. Vibrational Spectroscopic Studies of Cocrystals and Salts. 4. Cocrystal Products formed by Benzylamine, α-Methylbenzylamine, and their Chloride Salts , 2011 .
[25] Naír Rodríguez-Hornedo,et al. Role of Cocrystal and Solution Chemistry on the Formation and Stability of Cocrystals with Different Stoichiometry , 2009 .
[26] U. Griesser,et al. The effect of water vapor pressure on desolvation kinetics of caffeine 4/5-hydrate , 1995 .
[27] William Jones,et al. Recent Advances in Understanding the Mechanism of Cocrystal Formation via Grinding , 2009 .
[28] B. K. Hodnett,et al. Understanding the p-Toluenesulfonamide/Triphenylphosphine Oxide Crystal Chemistry: A New 1:1 Cocrystal and Ternary Phase Diagram , 2012 .
[29] J. Baruah,et al. Water Bridged Assembly and Dimer Formation in Co-Crystals of Caffeine or Theophylline with Polycarboxylic Acids , 2011 .
[30] A. Myerson,et al. Separation of impurities from solution by selective co-crystal formation , 2012 .
[31] Tom Leyssens,et al. Innovative chiral resolution using enantiospecific cocrystallization in solution , 2012 .
[32] Bing-Shiou Yang,et al. A Practical Solid Form Screen Approach To Identify a Pharmaceutical Glutaric Acid Cocrystal for Development , 2009 .
[33] N. Candoni,et al. Importance of Solvent Selection for Stoichiometrically Diverse Cocrystal Systems: Caffeine/Maleic Acid 1:1 and 2:1 Cocrystals , 2012 .
[34] V. Lehto,et al. A kinetic study of polymorphic transition of anhydrous caffeine with microcalorimeter , 1998 .
[35] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[36] P. W. Cains,et al. Discovering New Co-Crystals , 2009 .
[37] Christer B. Aakeröy,et al. Building co-crystals with molecular sense and supramolecular sensibility , 2005 .
[38] L. Fábián,et al. Exploring the relationship between cocrystal stability and symmetry: is Wallach's rule applicable to multi-component solids? , 2008, Chemical communications.
[39] A. Nangia,et al. Pharmaceutical Cocrystals of Niclosamide , 2012 .
[40] R. Tan,et al. Operating Regions in Cooling Cocrystallization of Caffeine and Glutaric Acid in Acetonitrile , 2010 .
[41] H. Fun,et al. Model pharmaceutical co-crystallization: Guest-directed assembly of caffeine and aromatic tri-hydroxy and dicarboxylic acids into different heteromolecular hydrogen bonding networks in solid state , 2010 .
[42] Sarah J. Nehm,et al. Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation , 2006 .
[43] William Jones,et al. Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .
[44] N. Rodríguez-Hornedo,et al. Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine , 2008 .
[45] T. Leyssens,et al. Advances in pharmaceutical Co-crystal screening: Effective Co-crystal screening through structural resemblance , 2012 .
[46] P. Bag,et al. A kinetically controlled crystallization process for identifying new co-crystal forms: fast evaporation of solvent from solutions to dryness , 2011 .
[47] E. Haslam,et al. Polyphenol–caffeine complexation , 1986 .
[48] T. Leyssens,et al. Ternary and quaternary phase diagrams: key tools for chiral resolution through solution cocrystallization , 2013 .
[49] D. Verdoes,et al. Electrochemically induced co-crystallization for product removal , 2011 .
[50] F. Puel,et al. Cocrystal Formation in Solution: In Situ Solute Concentration Monitoring of the Two Components and Kinetic Pathways , 2009 .
[51] William Jones,et al. Solvent-drop grinding: green polymorph control of cocrystallisation. , 2004, Chemical communications.
[52] J. Trotter,et al. Crystal and molecular structure of 1,3,7‐trimethyl‐2,6‐purinedione hydrochloride dihydrate (caffeine hydrochloride dihydrate) , 1978 .
[53] C. C. Seaton,et al. Co-Crystallization in the Caffeine/Maleic Acid System: Lessons from Phase Equilibria , 2010 .
[54] H. Edwards,et al. Metamorphosis of caffeine hydrate and anhydrous caffeine , 1997 .
[55] A. Seidel-Morgenstern,et al. Enantiomeric mandelic acid system-melting point phase diagram and solubility in water , 2002 .